|
Schering to meet targets
|
 |
July 12, 2000: 11:56 a.m. ET
Drug maker tells analysts it will meet 2Q, full-year earnings estimates
|
NEW YORK (CNNfn) - Executives with drug maker Schering-Plough Corp. told analysts Wednesday the company will meet earnings estimates in the second quarter and would be in line with forecasts for the full year.
The company did not release a full earnings report, but Richard Jay Kogan, chairman and chief executive of the company, told analysts the earnings would come in at 43 cents a share when it releases results July 25. That is the same as the estimates of analysts surveyed by earnings tracker First Call.
Kogan also said the full-year result would be in line with current forecasts of $1.64 a share.
Worldwide pharmaceuticals, which make up 84 percent of the company's total sales, continue to drive Schering-Plough's growth, he said.
Shares of Schering-Plough (SGP: Research, Estimates) fell 5/8 to 50-5/16 in trading Wednesday. 
|
|
|
|
|
|
Schering Plough
|
Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney
|
|
|
|
 |
|
